Rapamycin restores brain vasculature, metabolism, and blood-brain barrier in an inflammaging model

[1]  M. Mattson,et al.  Age-related impairment of cerebral blood flow response to KATP channel opener in Alzheimer’s disease mice with presenilin-1 mutation , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  Xin Yi,et al.  Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis. , 2020, Life sciences.

[3]  B. Miller,et al.  Molecular changes associated with spinal cord aging , 2020, GeroScience.

[4]  K. Sataranatarajan,et al.  Molecular changes associated with spinal cord aging , 2020, GeroScience.

[5]  Zhenhong Wei,et al.  Perturbation of Ephrin Receptor Signaling and Glutamatergic Transmission in the Hypothalamus in Depression Using Proteomics Integrated With Metabolomics , 2019, Front. Neurosci..

[6]  M. Henkemeyer,et al.  EphB2 receptor cell-autonomous forward signaling mediates auditory memory recall and learning-driven spinogenesis , 2019, Communications Biology.

[7]  N. Smith,et al.  Anti-inflammatory agent, OKN-007, reverses long-term neuroinflammatory responses in a rat encephalopathy model as assessed by multi-parametric MRI: implications for aging-associated neuroinflammation , 2019, GeroScience.

[8]  Ji-xian Wang,et al.  Rapamycin Increases Collateral Circulation in Rodent Brain after Focal Ischemia as detected by Multiple Modality Dynamic Imaging , 2019, Theranostics.

[9]  T. Sargeant,et al.  Rapamycin and Alzheimer disease: a double-edged sword? , 2019, Autophagy.

[10]  W. Yao,et al.  Increased BBB permeability contributes to EGCG-caused cognitive function improvement in natural aging rats: pharmacokinetic and distribution analyses , 2019, Acta Pharmacologica Sinica.

[11]  Chao Ma,et al.  Rapamycin regulates cholesterol biosynthesis and cytoplasmic ribosomal proteins in hippocampus and temporal lobe of APP/PS1 mouse , 2019, Journal of the Neurological Sciences.

[12]  Wei Bi,et al.  Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice , 2019, Scientific Reports.

[13]  E. Wang,et al.  1H-MRS Quantitation of Age-Dependent Taurine Changes in Mouse Brain , 2019, Molecular Imaging and Biology.

[14]  S. Rizvi,et al.  Rapamycin Confers Neuroprotection Against Aging-Induced Oxidative Stress, Mitochondrial Dysfunction, and Neurodegeneration in Old Rats Through Activation of Autophagy. , 2019, Rejuvenation research.

[15]  M. V. Tenditnik,et al.  Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease , 2019, Pharmacology Biochemistry and Behavior.

[16]  E. Aronica,et al.  Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo — in search of potential anti-epileptogenic strategies for temporal lobe epilepsy , 2018, Journal of Neuroinflammation.

[17]  Cai-Hong Yang,et al.  Effects of long-term rapamycin treatment on glial scar formation after cryogenic traumatic brain injury in mice , 2018, Neuroscience Letters.

[18]  M. Lerner,et al.  Assessing long-term neuroinflammatory responses to encephalopathy using MRI approaches in a rat endotoxemia model , 2018, GeroScience.

[19]  S. Green,et al.  Age Drives Distortion of Brain Metabolic, Vascular and Cognitive Functions, and the Gut Microbiome , 2017, Front. Aging Neurosci..

[20]  M. Fang,et al.  The post‐therapeutic effect of rapamycin in mild traumatic brain‐injured rats ensuing in the upregulation of autophagy and mitophagy , 2017, Cell biology international.

[21]  H. Weiss,et al.  Rapamycin decreased blood-brain barrier permeability in control but not in diabetic rats in early cerebral ischemia , 2017, Neuroscience Letters.

[22]  Ying-chun Liu,et al.  Rapamycin suppresses Aβ25–35- or LPS-induced neuronal inflammation via modulation of NF-κB signaling , 2017, Neuroscience.

[23]  Wang-Tso Lee,et al.  Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures , 2017, Journal of Neuroinflammation.

[24]  Yiyu Deng,et al.  Rapamycin inhibits lipopolysaccharide-induced neuroinflammation in vitro and in vivo , 2016, Molecular medicine reports.

[25]  H. Zhang,et al.  Rapamycin protects against neuronal death and improves neurological function with modulation of microglia after experimental intracerebral hemorrhage in rats. , 2016, Cellular and molecular biology.

[26]  Kathleen F. Kerr,et al.  Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice , 2016, eLife.

[27]  H. Weiss,et al.  Effects of rapamycin pretreatment on blood-brain barrier disruption in cerebral ischemia-reperfusion , 2016, Neuroscience Letters.

[28]  M. Greenberg,et al.  EphB1 and EphB2 intracellular domains regulate the formation of the corpus callosum and anterior commissure , 2016, Developmental neurobiology.

[29]  Dong-Hyun Kim,et al.  Gut microbiota lipopolysaccharide accelerates inflamm-aging in mice , 2016, BMC Microbiology.

[30]  E. Aronica,et al.  Blood–brain barrier leakage after status epilepticus in rapamycin‐treated rats II: Potential mechanisms , 2016, Epilepsia.

[31]  E. Aronica,et al.  Blood–brain barrier leakage after status epilepticus in rapamycin‐treated rats I: Magnetic resonance imaging , 2016, Epilepsia.

[32]  Wei Zhang,et al.  Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  Qi-min Song,et al.  Rapamycin protects neurons from brain contusion-induced inflammatory reaction via modulation of microglial activation , 2015, Molecular medicine reports.

[34]  Y. Gupta,et al.  Rapamycin ameliorates brain metabolites alterations after transient focal ischemia in rats. , 2015, European journal of pharmacology.

[35]  Lin Zhu,et al.  Rapamycin protects against apoptotic neuronal death and improves neurologic function after traumatic brain injury in mice via modulation of the mTOR-p53-Bax axis. , 2015, The Journal of surgical research.

[36]  A. Constanti,et al.  Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release , 2014, Brain, Behavior, and Immunity.

[37]  C. Franceschi,et al.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[38]  K. Khalili,et al.  TNF-α/NF-κB Signaling in the CNS: Possible Connection to EPHB2 , 2014, Journal of Neuroimmune Pharmacology.

[39]  M. Ono,et al.  A novel autoantibody against ephrin type B receptor 2 in acute necrotizing encephalopathy , 2013, Journal of Neuroinflammation.

[40]  P. Fox,et al.  Chronic Rapamycin Restores Brain Vascular Integrity and Function Through NO Synthase Activation and Improves Memory in Symptomatic Mice Modeling Alzheimer’s Disease , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  M. Blagosklonny,et al.  Rapamycin suppresses brain aging in senescence-accelerated OXYS rats , 2013, Aging.

[42]  Stephanie D. Kraft-Terry,et al.  Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain , 2013, Journal of Neuroimmune Pharmacology.

[43]  Maria A. Woodward,et al.  Rapamycin slows aging in mice , 2012, Aging cell.

[44]  Eleonora Aronica,et al.  Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood–brain barrier leakage but not microglia activation , 2012, Epilepsia.

[45]  Phil Lee,et al.  Effects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice , 2012, Experimental Neurology.

[46]  M. Hall,et al.  Rapamycin passes the torch: a new generation of mTOR inhibitors , 2011, Nature Reviews Drug Discovery.

[47]  R. D'Agostino,et al.  Aging masks detection of radiation-induced brain injury , 2011, Brain Research.

[48]  B. Carnes,et al.  Basal and hypercapnia-altered cerebrovascular perfusion predict mild cognitive impairment in aging rodents , 2009, Neuroscience.

[49]  Pierluigi Navarra,et al.  Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation. , 2009, Biochemical pharmacology.

[50]  Peter Jezzard,et al.  Comparison of hypercapnia‐based calibration techniques for measurement of cerebral oxygen metabolism with MRI , 2009, Magnetic resonance in medicine.

[51]  D. Sretavan,et al.  Upregulation of EphB2 and ephrin-B2 at the optic nerve head of DBA/2J glaucomatous mice coincides with axon loss. , 2007, Investigative ophthalmology & visual science.

[52]  Michelle N. Ngo,et al.  Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus , 2003, The Journal of cell biology.

[53]  G. Crelier,et al.  Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: The deoxyhemoglobin dilution model , 1999, Magnetic resonance in medicine.

[54]  Elena B. Pasquale,et al.  The Eph family: a multitude of receptors that mediate cell recognition signals , 1997, Cell and Tissue Research.

[55]  E. London,et al.  Regional cerebral blood flow during development and ageing of the rat brain. , 1981, Brain : a journal of neurology.

[56]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .